N-(2-Methoxy-5-(4-(2-morpholinoethyl)-3-oxo-3,4-dihydro-2Hbenzo[b][1,4]oxazin-6-yl)pyridin-3-yl)butane-1-sulfonamide

ID: ALA4244827

PubChem CID: 145983076

Max Phase: Preclinical

Molecular Formula: C24H32N4O6S

Molecular Weight: 504.61

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCS(=O)(=O)Nc1cc(-c2ccc3c(c2)N(CCN2CCOCC2)C(=O)CO3)cnc1OC

Standard InChI:  InChI=1S/C24H32N4O6S/c1-3-4-13-35(30,31)26-20-14-19(16-25-24(20)32-2)18-5-6-22-21(15-18)28(23(29)17-34-22)8-7-27-9-11-33-12-10-27/h5-6,14-16,26H,3-4,7-13,17H2,1-2H3

Standard InChI Key:  ILZGSFYGRSIBQZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    1.7499  -11.3292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1627  -10.6235    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.3451  -10.6189    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1668  -12.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1668  -13.0792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8721  -13.4837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5774  -13.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5774  -12.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8721  -11.8493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2840  -13.4922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2809  -14.3103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9839  -14.7199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9902  -13.0836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6978  -13.4976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6911  -14.3175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3939  -14.7308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1078  -14.3289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1144  -13.5091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4072  -13.0912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8258  -13.1070    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8721  -11.0321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4579  -11.8555    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7514  -12.2661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4126  -12.2740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1585   -9.8063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8642   -9.3941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8600   -8.5769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5657   -8.1648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1231  -11.8702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1285  -11.0530    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8410  -10.6513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8484   -9.8377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1453   -9.4206    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4330   -9.8232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4239  -10.6429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  4 22  1  0
 22 23  1  0
 19 24  1  0
  2 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 24 29  1  0
 29 30  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4244827

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.61Molecular Weight (Monoisotopic): 504.2043AlogP: 2.36#Rotatable Bonds: 10
Polar Surface Area: 110.30Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.89CX Basic pKa: 5.79CX LogP: 1.13CX LogD: 1.02
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.53Np Likeness Score: -1.70

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source